Home › Psoriatic Arthritis › Ohio
Pag-aaral pangklinika para sa Psoriatic Arthritis sa Ohio
14 pag-aaral para sa Psoriatic Arthritis ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Paramount Medical Research & Consulting, Middleburg Heights
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07321873A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 3
Edad 3 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06663332Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division, Cleveland
- Paramount Medical Research & Consulting, LLC, Middleburg Heights
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06671483Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Middleburg Heights
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division, Cleveland
- Paramount Medical Research & Consulting, LLC, Middleburg Heights
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Paramount Medical Research & Consulting, LLC, Middleburg Heights
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07286058A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- MetroHealth Medical Center /ID# 262377, Cleveland
- Cleveland Clinic - Cleveland /ID# 276655, Cleveland
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Metrohealth Medical Center, Cleveland
- at 2 pa
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT02418442A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Pa0019 144, Vandalia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT07290036A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- University Hospitals Cleveland Medical Center, Cleveland
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 3, 2026 · NCT06454188Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Paramount Medical Research and Consulting /ID# 272757, Middleburg Heights
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT06865105Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Cincy Arthritis, Blue Ash
- Southern Ohio Rheumatology, Wheelersburg
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 9, 2025 · NCT05669833IMPACT - AndHealth Autoimmune Research Registry
- AndHealth, Columbus
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 29, 2023 · NCT05883371Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.